Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Apo-Citalopram
Active Ingredient: Citalopram hydrobromide 25mg equivalent to citalopram 20mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Apotex NZ Limited
Manufacturer: Apotex Inc, Weston, Ontario, Canada
Product: Calci-Tabs Effervescent
Active Ingredient: Calcium carbonate 2,500mg equivalent to elemental calcium 1000mg
Dosage Form: Effervescent tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Losan Pharma GmbH, Neuenburg, Germany
Product: Calci-Tabs Effervescent
Active Ingredient: Calcium carbonate 1,250mg equivalent to elemental calcium 500mg
Dosage Form: Effervescent tablet
New Zealand Sponsor: AFT Pharmaceuticals Limited
Manufacturer: Losan Pharma GmbH, Neuenburg, Germany
Product: Flucoran
Active Ingredient: Fluconazole 150mg
Dosage Form: Capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India
Product: Flucoran
Active Ingredient: Fluconazole 200mg
Dosage Form: Capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India
Product: Flucoran
Active Ingredient: Fluconazole 50mg
Dosage Form: Capsule
New Zealand Sponsor: Douglas Pharmaceuticals Limited
Manufacturer: Ranbaxy Laboratories Limited, Dewas, Madhya Pradesh, India
Dated this 3rd day of March 2006.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on 6 July 2001).